InvestorsHub Logo
Followers 276
Posts 32701
Boards Moderated 0
Alias Born 11/14/2013

Re: inveterate post# 660783

Tuesday, 01/02/2024 12:21:18 PM

Tuesday, January 02, 2024 12:21:18 PM

Post# of 700872
No. In the cancer Merck treats best, melanoma, the percent decrease in likelihood of recurrence or death, with the added Moderna vaccine, decreased by at most, 49% in a phase 2 trial.

Whereas for DCVax-l, the increased chance for life at three years was much higher, and kept increasing over time.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News